Compare ECOR & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | LGL |
|---|---|---|
| Founded | 2005 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.3M | 85.1M |
| IPO Year | 2018 | 2017 |
| Metric | ECOR | LGL |
|---|---|---|
| Price | $7.17 | $6.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $19.17 | N/A |
| AVG Volume (30 Days) | ★ 67.9K | 6.2K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.50 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,032,000.00 | $4,169,000.00 |
| Revenue This Year | $30.85 | $89.49 |
| Revenue Next Year | $29.71 | $27.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.41 | $5.45 |
| 52 Week High | $12.70 | $7.88 |
| Indicator | ECOR | LGL |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 51.58 |
| Support Level | $6.94 | $6.80 |
| Resistance Level | $8.26 | $7.34 |
| Average True Range (ATR) | 0.69 | 0.15 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 26.75 | 73.58 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
LGL Group Inc is a holding company engaged in services, merchant investment, and manufacturing business activities. The company has two reportable segments: Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications, including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.